NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 272 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,250 | -18.1% | 2,408 | -23.7% | 0.01% | -27.3% |
| Q3 2022 | $27,173 | +63.6% | 3,156 | +130.9% | 0.01% | +83.3% |
| Q1 2022 | $16,609 | -73.9% | 1,367 | -26.7% | 0.01% | -71.4% |
| Q4 2021 | $63,600 | -32.7% | 1,864 | -4.9% | 0.02% | -40.0% |
| Q3 2021 | $94,550 | +13.5% | 1,960 | +6.3% | 0.04% | +16.7% |
| Q2 2021 | $83,293 | +15.1% | 1,844 | +22.9% | 0.03% | +7.1% |
| Q1 2021 | $72,345 | -5.0% | 1,500 | +6.1% | 0.03% | -12.5% |
| Q4 2020 | $76,130 | +45.9% | 1,414 | 0.0% | 0.03% | +28.0% |
| Q3 2020 | $52,162 | +19.1% | 1,414 | 0.0% | 0.02% | +8.7% |
| Q2 2020 | $43,806 | +18.4% | 1,414 | +5.5% | 0.02% | 0.0% |
| Q1 2020 | $36,997 | -14.3% | 1,340 | -9.2% | 0.02% | +4.5% |
| Q4 2019 | $43,173 | +55.8% | 1,476 | +1.9% | 0.02% | +46.7% |
| Q3 2019 | $27,705 | -12.9% | 1,449 | 0.0% | 0.02% | -16.7% |
| Q2 2019 | $31,791 | +131.2% | 1,449 | +115.6% | 0.02% | +125.0% |
| Q1 2019 | $13,749 | – | 672 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |